Revolutionize The Way Drugs Are Discovered & Developed
Currently, it takes 12 years and $2.6 billion to get a single drug to market, with the drug discovery and development process costing $1.4 billion. At Verge Genomics, we believe there is a better way: we aim to improve the traditional drug discovery process with approaches based on systems biology, machine learning on human patient data, and drug screening in human cell cultures.
We’ve raised $32 million in Series A financing to build a next-generation biopharmaceutical company focused on accelerating development of life-saving treatments for patients with neurodegenerative diseases, including ALS, Parkinson’s Disease, and Alzheimer’s Disease.
Patient Driven - Inspired and driven by the people who need us ♥️⚕💊
Team of Founders - We are each responsible for the success of the company and each other 🗝🦅
Transparency - Express ourselves with candor 🌤
Growth Mindset - Always seeking opportunities to improve 🌱
Grit - Persevere in the face of adversity 💪
Rigor - Supporting quality science 🔬
More About You
As an emerging startup, Verge Genomics provides growth opportunities into other areas of the company. Being one of the early employees at Verge, your work will have a direct impact on the foundation of a groundbreaking new drug development model. You will be empowered to own your work and makes real decisions.
In addition to competitive compensation and benefits, we offer perks like unlimited vacation/sick days, and free lunch delivered every day.